The fact that DTX3L was overexpressed in prostate cancer patient samples and that DTX3L overexpression inhibited HR and caused chromosomal instability prompted us to explore whether DTX3L overexpression sensitizes prostate cancer cells to synthetic lethality by PARP inhibitors. This evidence concerns the gene DTX3L and prostate cancer.